Chiron may get $115 million as Roche settles IP (intellectual property) dispute
This article was originally published in Clinica
Executive Summary
The seven-year battle over intellectual property rights to probe-based diagnostics between Roche Diagnostics and Chiron has ended - in part, at least. Roche is to pay up to $115 million to license the rights to manufacture and sell probe-based tests for HCV and HIV.